Di Sarno, L.; Ferretti, S.; Capossela, L.; Gatto, A.; Pansini, V.; Manni, L.; Chiaretti, A.
Neurofunctional and Clinical Effects of Intranasal Human Recombinant Nerve Growth Factor in Children with Acquired Brain Injury. Pharmaceuticals 2026, 19, 590.
https://doi.org/10.3390/ph19040590
AMA Style
Di Sarno L, Ferretti S, Capossela L, Gatto A, Pansini V, Manni L, Chiaretti A.
Neurofunctional and Clinical Effects of Intranasal Human Recombinant Nerve Growth Factor in Children with Acquired Brain Injury. Pharmaceuticals. 2026; 19(4):590.
https://doi.org/10.3390/ph19040590
Chicago/Turabian Style
Di Sarno, Lorenzo, Serena Ferretti, Lavinia Capossela, Antonio Gatto, Valeria Pansini, Luigi Manni, and Antonio Chiaretti.
2026. "Neurofunctional and Clinical Effects of Intranasal Human Recombinant Nerve Growth Factor in Children with Acquired Brain Injury" Pharmaceuticals 19, no. 4: 590.
https://doi.org/10.3390/ph19040590
APA Style
Di Sarno, L., Ferretti, S., Capossela, L., Gatto, A., Pansini, V., Manni, L., & Chiaretti, A.
(2026). Neurofunctional and Clinical Effects of Intranasal Human Recombinant Nerve Growth Factor in Children with Acquired Brain Injury. Pharmaceuticals, 19(4), 590.
https://doi.org/10.3390/ph19040590
